Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)

Market Cap	3.52B +7.4%
Revenue (ttm)	825.20M +12.7%
Net Income	94.51M -23.2%
EPS	0.23 -23.2%
Shares Out	419.95M
PE Ratio	37.24
Forward PE	n/a
Dividend	0.04 (0.48%)
Ex-Dividend Date	Jun 27, 2025

Volume	5,390,499
Average Volume	9,422,368
Open	8.56
Previous Close	8.42
Day's Range	8.32 - 8.56
52-Week Range	6.38 - 9.48
Beta	0.40
RSI	58.28
Earnings Date	Apr 29, 2026

About SHE:300636

Jiangxi Synergy Pharmaceutical Co., Ltd. engages in research and development, production, and sales of chemical raw materials and pharmaceutical intermediates in China and internationally. The company offers nervous system drugs, digestive system medications, antipyretic analgesics and non-steroidal anti-inflammatory analgesics, antihypertensive drugs, anticoagulants, hypoglycemic drugs, antidepressants, as well as antigout and urinary system medications. It also exports its products to Europe, the United States, Japan, South Korea, and other r...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 1,418
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300636

Financial Performance

In 2024, SHE:300636's revenue was 758.89 million, an increase of 5.09% compared to the previous year's 722.14 million. Earnings were 106.58 million, an increase of 0.57%.